Transforming Growth Factor-β and the Immune Response: Implications for Anticancer Therapy

Immune homeostasis is a delicate balance between the immune defense against foreign pathogens and suppression of the immune system to maintain self-tolerance and prevent autoimmune disease. Maintenance of this balance involves several crucial networks of cytokines and various cell types. Among these...

Full description

Saved in:
Bibliographic Details
Published in:Clinical cancer research 2007-09, Vol.13 (18), p.5262-5270
Main Authors: WRZESINSKI, Stephen H, WAN, Yisong Y, FLAVELL, Richard A
Format: Article
Language:English
Subjects:
Animals
Antineoplastic agents
Biological and medical sciences
Dendritic Cells - immunology
Humans
Immune Response
Killer Cells, Natural - immunology
Medical sciences
Neoplasms - drug therapy
Neoplasms - immunology
Pharmacology. Drug treatments
T-Lymphocytes - immunology
TGF-β
Transforming Growth Factor beta - antagonists & inhibitors
Transforming Growth Factor beta - physiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Immune homeostasis is a delicate balance between the immune defense against foreign pathogens and suppression of the immune system to maintain self-tolerance and prevent autoimmune disease. Maintenance of this balance involves several crucial networks of cytokines and various cell types. Among these regulators, transforming growth factor-β (TGF-β) is a potent cytokine with diverse effects on hematopoietic cells. Its pivotal function within the immune system is to maintain tolerance via the regulation of lymphocyte proliferation, differentiation, and survival. In addition, TGF-β controls the initiation and resolution of inflammatory responses through the regulation of chemotaxis and activation of leukocytes in the periphery, including lymphocytes, natural killer cells, dendritic cells, macrophages, mast cells, and granulocytes. Through its pleiotropic effects on these immune cells, TGF-β prevents the development of autoimmune diseases without compromising immune responses to pathogens. However, overactivation of this pathway can lead to several immunopathologies under physiologic conditions including cancer progression, making it an attractive target for antitumor therapies. This review discusses the biological functions of TGF-β and its effects on the immune system and addresses how immunosuppression by this cytokine can promote tumorigenesis, providing the rationale for evaluating the immune-enhancing and antitumor effects of inhibiting TGF-β in cancer patients.
ISSN:1078-0432
1557-3265
DOI:10.1158/1078-0432.CCR-07-1157